The new generation double syringe system Arthrex ACP® Double Syringe

The new generation double syringe system Arthrex ACP® Double Syringe
  • 2020 December 13

We are proud to present a unique novelty, the new generation double syringe system Arthrex ACP® Double Syringe, designed for (Trombocites autocell injections) treatments. We have selected German producer Arthrex that have gained their name as one of the global biotechnology leaders because of this medical device!

Arthrex ACP® Double Syringe is a scientifically based system that has been around for many years and stands out by the following advantages:

– Faster, easier, safer
(Trombocites autocell injections) is prepared as fast as in 4-5 minutes and, thanks to the double syringe solution, is injected directly from the syringe: less steps means less chance for mistakes and a faster process. Sterile and safe!

– Less pain for the patient. „Natural“ has become even more natural!
No need for anticoagulants and activators that trigger the burning sensation during injection. Therefore the patient is given a totally different kind of experience – thanks to Arthrex ACP® Double Syringe the treatment is nearly painless. (Trombocites autocell injections) becomes even more natural!

– Safety
A closed, sterile, no-needle system is produced in Germany and has 2b class medical device certificate as well as DIN ISO 13485 quality certificate. Injecting (Trombocites autocell injections) directly from the syringe ensures higher safety of the procedure, since no anticoagulants or cell attracting gel is used.

– Efficiency
An average of 5-6 ml (Trombocites autocell injections) ir prepared from 15 ml of blood, and the platelets concentration is around 2,5 times higher than the concentration that other systems provide.